Issues
-
Cover Image
Cover Image
Squamous cell carcinomas of the uterine cervix were subjected to dynamic contrast-enhanced magnetic resonance imaging by using gadolinium diethylene-triamine penta-acetic acid (Gd-DTPA) as contrast agent and an axial T1-weighted spoiled gradient recalled sequence for imaging. The T1-weighted images showed a high-signal intensity rim in the tumor periphery immediately after the contrast administration, and this rim moved outwards with time. The velocity of the rim movement at the tumor surface was associated with tumor interstitial fluid pressure and incidence of lymph node metastases, and may serve as a novel general biomarker of interstitial hypertension-induced tumor aggressiveness. For details, see article by Hompland and colleagues on page 4899. - PDF Icon PDF LinkTable of Contents
Cancer Research
Table of Contents
Breaking Advances
Reviews
Commentary
Integrated Systems and Technologies
Microenvironment and Immunology
Molecular and Cellular Pathobiology
Frequent PVT1 Rearrangement and Novel Chimeric Genes PVT1-NBEA and PVT1-WWOX Occur in Multiple Myeloma with 8q24 Abnormality
Prevention and Epidemiology
Biomarkers of HPV in Head and Neck Squamous Cell Carcinoma
Therapeutics, Targets, and Chemical Biology
FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy
Inactivation of the HIF-1α/PDK3 Signaling Axis Drives Melanoma toward Mitochondrial Oxidative Metabolism and Potentiates the Therapeutic Activity of Pro-Oxidants
MEN1 Gene Replacement Therapy Reduces Proliferation Rates in a Mouse Model of Pituitary Adenomas
Tumor and Stem Cell Biology
Induction of the Stem-like Cell Regulator CD44 by Rho Kinase Inhibition Contributes to the Maintenance of Colon Cancer–Initiating Cells
Adenylate Kinase-4 Is a Marker of Poor Clinical Outcomes That Promotes Metastasis of Lung Cancer by Downregulating the Transcription Factor ATF3
Correction
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.